Analyst Ratings for Biogen (BIIB)
BIIB Rating Summary
BIIB Price Target Summary
- Highest: $398.00 (Goldman Sachs)
- Lowest: $242.00 (DZ Bank)
- Average: $320.26
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$320.26 (+38%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 75%
Avg. $ Target:
$320.26 (+38%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/6/2023 | HSBC | Morten Herholdt | New Coverage | Buy (N/A) |
360.00 (N/A) |
267.17 (232.06) |
-13.14% | Details |
| 7/27/2023 | Scotiabank » Updated 7/31/2023 |
Hal Goetsch | New Coverage | Sector Outperform (N/A) |
304.00 (327.00) |
270.31 (232.06) |
-14.15% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
